Charles River Collaborates with Fios Genomics for Bioinformatics-Driven Drug Discovery and Safety Assessment
Shots:
- The collaboration provides Charles River’s client access to Fios Genomics’ expertise in bioinformatics- statistics and biology- assisting the sourcing and analysis datasets associated with the drug development including microarrays- NGS- proteomics- metabolomics- epigenetics and associated meta-data
- The agreement merges Fios’ biologically-relevant insights with Charles River’s drug discovery and development platform and the scientific expertise of both the companies
- The focus of the agreement is to accelerate preclinical- discovery and development by turning complex data into actionable information. Charles River’s clients will be able to make data-driven decisions about their programs thus leading to an improvement in speed
Click here to read full press release/ article | Ref: Charles River | Image: Mayo news
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com